~30% of the human genome encodes membrane proteins.
Over 50% of all known drugs target membrane proteins.
Lipid membranes make up only 6–12% of cytosolic volume, with 2–5% from the plasma membrane.
Of ~1195 known protein folds, only 58 (~5%) are membrane protein folds.
GPCR family (G-Protein Coupled Receptors).
Regulates glucose homeostasis.
Process:
Agonist binds extracellularly.
Triggers intracellular signalling cascade.
Results in increased insulin secretion.
Targeted by drug Semaglutide.
Composed of lipids (15–75%) and proteins.
Selectively permeable: allows specific molecule passage.
Architecture varies by organism:
Bacteria: Gram-positive & Gram-negative.
Eukaryotes: Plasma membrane, organelles (e.g. mitochondria).
Compartmentalisation
Scaffold for biochemical reactions
Selective permeability
Solute transport
Signal reception
Intracellular communication
Energy transduction
Two membranes.
Thin peptidoglycan layer in the periplasmic space.
Outer membrane is more permeable.
Thick peptidoglycan wall.
Single membrane.
Peptidoglycan: Polymer of amino acids + sugars. Unique to bacteria.
Double lipid bilayers in organelles such as:
Mitochondria
Nucleus
Sheet-like, lipid & protein structure.
Hydrophilic (head) and hydrophobic (tail) regions.
Non-covalent assembly.
Asymmetric, fluid, and electrically polarised.
4 major biomolecule groups:
Lipids
Nucleic acids
Proteins
Polysaccharides
Phosphoglycerides:
Glycerol backbone
2 fatty acids (C1 & C2), phosphate at C3.
Variable alcohol group → affects charge and interactions.
Cardiolipin (CL):
Inner mitochondrial membrane (20% of lipids).
2 phospholipids + glycerol.
Involved in cristae formation and apoptosis (cytochrome c release).
Sphingolipids:
Backbone = sphingosine (C18 amino alcohol).
Includes:
Sphingomyelin (phosphorylcholine)
Ceramide (with fatty acid)
Cerebrosides (with sugar)
Gangliosides (with sialic acid)
30–40% of plasma membrane lipids.
Rigid structure → decreases fluidity.
Lipid composition varies by:
Chemical structure → specific functions.
Ratio (composition) → affects behaviour.
Impermeable to ions & most polar molecules.
Small molecule permeability depends on hydrophobicity.
Phosphatidylserine (PS):
Normally on inner leaflet.
If on outer → signals apoptosis.
Lipids are not static; they hop between regions.
Hop diffusion:
Rapid local diffusion.
Occasional hopping across barriers (e.g. spectrin-actin fences).
Defines cell shape, esp. in erythrocytes.
Spectrin (α-helical coil) + Ankyrin + integral proteins → structure and fencing.
Integral: Require detergents for removal.
Peripheral: Easily removed.
Amphitropic: Associate reversibly (regulated by ligands or phosphorylation).
Singer & Nicolson (1972): Proteins float in a lipid sea.
Updated model includes:
Asymmetry
Lipid rafts
Immobile regions
N-terminal domain is trypsin-accessible (extracellular).
Oligosaccharides only on outside.
Important in malaria (plasmodium) invasion.
Basis for M and N blood groups (Ser1Leu, Gly5Glu).
Exists as a dimer, with helix-helix interactions (mediated by Gly, Ala, Ser).
60% carbohydrate: prevents cell clumping.
40% protein
20aa transmembrane helix: hydrophobic residues.
Hydropathy scale used to predict membrane-spanning segments.
Insertion energetics:
Hydrophobic gain: -36 kcal/mol
Dehydration cost: +26 kcal/mol
Net ΔG: -10 kcal/mol
Even number of β-strands.
N/C-termini in periplasm.
Tilt: ~45°.
Antiparallel strands.
Short turns (T1, T2) periplasmic side.
Long loops (L1, L2) extracellular.
Aromatic girdles (Tyr, Trp) at interfaces.
Outer membrane of Gram-negative bacteria, mitochondria, chloroplasts.
Channels for small hydrophilic molecules (<600 Da).
High-resolution structures exist (crystallisation is challenging).
Membrane core = non-polar (~3 nm), with polar headgroups (~1.5 nm interface).
Amino acid location by region:
Core: Non-polar residues.
Interface: Tyr, Trp.
Aqueous phase: Charged residues.
Domains rich in sphingolipids + cholesterol.
Thicker, more ordered, and less fluid.
Enriched in GPI-anchored proteins.
Size: ~500 nm, dynamic (lifespan in milliseconds).
Aid in protein co-localisation.
Challenges:
Low expression levels.
Poor solubility in detergents.
Difficult purification.
Crystallisation issues.
Biochemical studies are more complex due to native lipid/protein interference